Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
26 Cards in this Set
- Front
- Back
|
What Tumor Marker is useful in monitoring effectiveness of prostate cancer treatment?
|
PSA
pg. 864 |
|
|
What Tumor Marker is useful in evaluating for recurrence after treatment has ended for Prostate Cancer?
|
PSA
pg. 864 |
|
|
This tumor marker may be elevated in men with benign prostate conditions?
|
PSA
pg. 864 |
|
|
True or False:
If a man has a benign prostate condition, the tumor marker PSA can distinguish between this and a malignant condition |
False:
PSA cannot distinguish between benign conditions and malignant conditions pg. 864 |
|
|
This tumor mark is elevated in ovarian cancer and some nonmalignant conditions?
|
CA 125
pg. 864 |
|
|
This tumor marker is used to monitor the treatment of ovarian cancer or to detect recurrence?
|
CA 125
pg. 864 |
|
|
True or False:
Any condition that inflames the pleura, such as endometriosis, PID, peritonitis, pancreatitis, liver disease can elevate the tumor marker CA 125 |
True
pg. 864 |
|
|
True or False:
Menstruation and pregnancy have no effect on tumor marker CA 125 |
False:
They can both elevate this marker. pg. 864 |
|
|
What tumor marker is used to identify colorectal cancer?
|
CEA (carcinoembryonic antigen)
pg. 865 |
|
|
Melanoma, lymphoma, lung, breast, pancreas, stomach, bladder, kdney, cervix, thyroid, liver, ovary all can produce an elevated level of what tumor marker?
|
CEA
pg. 865 |
|
|
What tumor marker is used after treatment to monitor for recurrence of colorectal cancer?
|
CEA
pg. 865 |
|
|
True or False:
CEA shows mild elevations common in smokers? |
True
pg. 865 |
|
|
Elevations of this tumor marker are seen in nonmalignant conditions such as inflammaroty bowel disease, pancreatitis, and liver disease?
|
CEA
pg. 865 |
|
|
This tumor marker is normally produced by the developing fetus?
|
α-FP
pg. 865 |
|
|
An elevation in this tumor marker is seen in adults, which suggests either primary liver or germ cell cancer?
|
α-FP
pg. 865 |
|
|
The following noncancerous conditions can cause elevation to this tumor marker: hepatitis, ataxia-telangiectasia, Wiskott-Aldrich syndrome, yolk sac.
|
α-FP
pg. 865 |
|
|
This tumor marker is elevated with colorectal cancer and other GI malignancies?
|
CA 19-9
pg. 865 |
|
|
This tumor marker is elevated with pancreatic cancer
|
CA 19-9
(the higher the marker, the more advanced the disease) pg. 865 |
|
|
True or False:
The following noncancerous conditions may elevate the tumor marker CA 19-9: pancreatitis, gallstones, cholecystitis, and cirrhosis. |
True
pg. 865 |
|
|
This tumor marker is used to identify advanced breast cancer?
|
CA 15-3
pg. 865 |
|
|
True or False:
CA 15-3 is often elevated in the early-stages of breast cancer? |
False:
It is only elevated in about 10% at an early-stage. pg. 865 |
|
|
This tumor marker may be elevated with benign breast or ovarian disease, PID, hepatitis, pregnancy and lactation.
|
CA 15-3
pg. 865 |
|
|
This tumor marker is used to check for recurrence of stage II and III breast cancer?
|
CA 27-29
pg. 865 |
|
|
True or False:
CA 27-29 is not elevated with nonmalignant conditions such as pregnancy, endometriosis, ovarian cysts, or benign breast disease? |
False:
The elevate this tumor marker. pg. 865 |
|
|
This tumor marker is seen elevated in most cancers?
|
LDH
pg. 865 |
|
|
Trauma, heart failure, meningitis are all noncancerous and can cause this tumor marker to be elevated?
|
LDH
(also anemia) pg. 865 |
